QD Pharmaceuticals ULC
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- Q LANSOPRAZOLE prolonged-release capsule, hard 30 mg
- Q OMEPRAZOLE prolonged-release capsule, hard 20 mg
- Q PANTOPRAZOLE prolonged-release tablet 40 mg
- A10 - Antidiabéticos
- Q METFORMIN film-coated tablet 500 mg
- Q METFORMIN film-coated tablet 850 mg
- C08 - Bloqueantes del canal de calcio
- Q AMLODIPINE tablet 10 mg
- Q AMLODIPINE tablet 5 mg
- C10 - Agentes modificadores de los lípidos
- Q FENOFIBRATE MICRO capsule, hard 200 mg
- Q SIMVASTATIN film-coated tablet 10 mg
- Q SIMVASTATIN film-coated tablet 20 mg
- Q SIMVASTATIN film-coated tablet 40 mg
- D01 - Antifúngicos para uso dermatológico
- Q TERBINAFINE tablet 250 mg
- M03 - Relajantes musculares
- Q CYCLOBENZAPRINE film-coated tablet 10 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- Q ALENDRONATE tablet 70 mg
- N03 - Antiepilépticos
- Q TOPIRAMATE coated tablet 100 mg
- Q TOPIRAMATE coated tablet 25 mg
- N05 - Psicolépticos
- Q ZOPICLONE tablet 7.5 mg
- N06 - Psicoanalépticos
- Q CITALOPRAM coated tablet 20 mg
- Q FLUOXETINE capsule, hard 20 mg
- Q PAROXETINE film-coated tablet 10 mg
- Q PAROXETINE film-coated tablet 20 mg
- Q PAROXETINE film-coated tablet 30 mg
- Q SERTRALINE capsule, hard 100 mg
- Q SERTRALINE capsule, hard 25 mg
- Q SERTRALINE capsule, hard 50 mg